Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression

被引:160
作者
Bauer, MKA
Vogt, M
Los, M
Siegel, J
Wessellborg, S
Schulze-Osthoff, K
机构
[1] Univ Tubingen, Med Clin, Dept Internal Med 1, D-72076 Tubingen, Germany
[2] Univ Freiburg, Dept Virol, Freiburg, Germany
关键词
D O I
10.1074/jbc.273.14.8048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation-induced cell death of T lymphocytes requires the inducible expression of CD95 (APO-1/Fas) ligand, which triggers apoptosis in CD95-bearing target cells by an autocrine or paracrine mechanism. Although execution of the CD95 death pathway is largely independent of reactive oxygen intermediates, activation-induced cell death is blocked by a variety of antioxidants. In the present study, we investigated the involvement of redox processes in the regulation of CD95 ligand (CD95L) expression in Jurkat T cells. We show that various antioxidants potently inhibited the transcriptional activation of CD95L following T cell receptor litigation or stimulation of cells with phorbol ester and ionomycin. Conversely, a prooxidant such as hydrogen peroxide alone was able to increase CD95L expression. As detected by Western blot and cytotoxicity assays, functional expression of CD95L protein was likewise diminished by antioxidants. Inhibition of CD95L expression was associated with a decreased DNA binding activity of nuclear factor (NF)-kappa B, an important redox-controlled transcription factor. Moreover, inhibition of NF-kappa B activity by a transdominant I kappa B mutant attenuated CD95L expression. Our data suggest that, although reactive oxygen intermediates do not act as mediators in the execution phase of CD95-mediated apoptosis, they are involved in the transcriptional regulation of CD95L expression.
引用
收藏
页码:8048 / 8055
页数:8
相关论文
共 67 条
  • [61] GENERALIZED LYMPHOPROLIFERATIVE DISEASE IN MICE, CAUSED BY A POINT MUTATION IN THE FAS LIGAND
    TAKAHASHI, T
    TANAKA, M
    BRANNAN, CI
    JENKINS, NA
    COPELAND, NG
    SUDA, T
    NAGATA, S
    [J]. CELL, 1994, 76 (06) : 969 - 976
  • [62] PHOSPHORYLATION OF HUMAN I-KAPPA-B-ALPHA ON SERINE-32 AND SERINE-36 CONTROLS I-KAPPA-B-ALPHA PROTEOLYSIS AND NF-KAPPA-B ACTIVATION IN RESPONSE TO DIVERSE STIMULI
    TRAENCKNER, EBM
    PAHL, HL
    HENKEL, T
    SCHMIDT, KN
    WILK, S
    BAEUERLE, PA
    [J]. EMBO JOURNAL, 1995, 14 (12) : 2876 - 2883
  • [63] LYMPHOPROLIFERATION DISORDER IN MICE EXPLAINED BY DEFECTS IN FAS ANTIGEN THAT MEDIATES APOPTOSIS
    WATANABEFUKUNAGA, R
    BRANNAN, CI
    COPELAND, NG
    JENKINS, NA
    NAGATA, S
    [J]. NATURE, 1992, 356 (6367) : 314 - 317
  • [64] SENSITIZATION OF T-CELLS TO CD95-MEDIATED APOPTOSIS BY HIV-1 TAT AND GP120
    WESTENDORP, MO
    FRANK, R
    OCHSENBAUER, C
    STRICKER, K
    DHEIN, J
    WALCZAK, H
    DEBATIN, KM
    KRAMMER, PH
    [J]. NATURE, 1995, 375 (6531) : 497 - 500
  • [65] HIV-1 TAT POTENTIATES TNF-INDUCED NF-KAPPA-B ACTIVATION AND CYTOTOXICITY BY ALTERING THE CELLULAR REDOX STATE
    WESTENDORP, MO
    SHATROV, VA
    SCHULZEOSTHOFF, K
    FRANK, R
    KRAFT, M
    LOS, M
    KRAMMER, PH
    DROGE, W
    LEHMANN, V
    [J]. EMBO JOURNAL, 1995, 14 (03) : 546 - 554
  • [66] Williams MS, 1996, J IMMUNOL, V157, P2395
  • [67] ZANZAMI N, 1995, J EXP MED, V182, P367